NCT06438757CompletedPhase 2
Trial of JYB1904 in Patients With Allergic Asthma
Phase IIa Trial to Evaluate the Pharmacokinetic/Pharmacodynamic Characteristics and Safety of JYB1904 in Patients With Allergic Asthma
Source: ClinicalTrials.gov · Last updated 15 Jun 2026
Brief summary (registry, in English)
This phase IIa trial is meant to evaluate the pharmacokinetics, pharmacodynamics and safety of JYB1904 in patients with allergic asthma.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 69 (actual)
- First submitted
- 27 May 2024
- Start date
- 19 Jun 2024
- Primary completion date
- 20 Nov 2025
- Lead sponsor
- Jemincare
- Diseases
- Asthma
- NCT number
- NCT06438757
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 69
- From 19 Jun 2024 to the primary completion date, 20 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior exposure to anti-IgE therapy within 1 year;
Other illness
- Allergic to anti-IgE biologics;
- Combined with other non-allergic diseases that cause IgE elevation；
- History of malignancy, autoimmune diseases, Immune complex mediated diseases, Hypereosinophilic syndrome;
- Other conditions unsuitable for the trial judged by the investigator.
Other
- Current smokers, or quit smoking within 1 year;
Who the study is looking for
- Able to provide written informed consent voluntarily;
- Aged 18-75 years, weight ≥ 40 kg, male or female;
- Diagnosed Allergic asthma.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai General Hospital Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.